© 2020 MJH Life Sciences and OncLive. All rights reserved.
January 28, 2020
Jeff Yorio, MD, discusses treatment options for patients with rare mutations in metastatic lung cancer.
January 18, 2020
Jeff Yorio, MD, discusses the search for biomarkers and using next-generation sequencing in metastatic lung cancer.
October 22, 2019
Jeff Yorio, MD, discusses a small phase II study that is looking at using ado-trastuzumab emtansine to treat patients with HER2-mutant metastatic lung cancer.